Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

New COVID-19 variant in South Africa as massive surge in Europe infections

November 26, 2021 Medical Communications

A new variant of coronavirus found in South Africa is feared to be more transmissible than other strains, and poses …
News

Allorion gains $40 million funding to enhance and discover precision targets

November 26, 2021 Medical Communications

Allorion Therapeutics has announced that they have gained $40 million in Series A financing. The funding was led by Chinese …
News

Pfizer seek EUA for novel COVID treatment pill

November 19, 2021 Medical Communications

Pfizer is seeking FDA Emergency Use Authorisation (EUA) for the novel oral antiviral, Paxlovid. The pill, if authorised, will help …
News

ImmunityBio expands COVID-19 vaccine programme to incorporate ‘mix-and-match’ technologies

November 19, 2021 Medical Communications

Clinical-stage immunotherapy company, ImmunityBio Inc, has announced the expansion of the company’s cancer and infectious disease vaccine programmes to include …
News

FDA approve Keytruda as adjuvant treatment for kidney cancer

November 19, 2021 Medical Communications

The FDA has approved Keytruda® for the treatment of patients with early renal cell carcinoma at high or intermediate-high risk …
News
nice_reception_manc_3_2_1

NICE recommends at-home treatment for spinal muscular atrophy

November 19, 2021 Medical Communications

NICE has recommended risdiplam as treatment for the rare genetic disorder, spinal muscular atrophy, as part of a managed access …
News

Biogen’s Aduhelm shown to reduce clinical decline in Alzheimer’s disease

November 12, 2021 Medical Communications

New ADUHELM (aducanumab-avwa) Phase III data has shown a positive correlation between plasma p-tau reduction and less cognitive and functional …
News

Blood pressure drugs could protect against type 2 diabetes

November 12, 2021 Medical Communications

Researchers have found that blood pressure drugs may directly reduce people’s risk of type 2 diabetes, a condition that an …
News
mat-napo-pij34zrzeew-unsplash

Trial investigates whether immunosuppressant holiday boosts vaccine protection

November 12, 2021 Medical Communications

A trial has been launched to evaluate how to increase COVID-19 vaccine protection among vulnerable patients taking immunosuppressant drugs . …
News

Kintor Pharma begins Phase II trial of KX-826 for androgenetic alopecia treatment

November 12, 2021 Medical Communications

Kintor Pharma, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the company has dosed the …
News

BIAL appoints Joerg Holenz as R&D General Manager

November 8, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bial, appointments

BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after …
Appointment

FDA decline Emergency Use Authorisation for ZYESAMI® in patients with critical COVID

November 5, 2021 Medical Communications

The FDA has declined to grant Emergency Use Authorisation for NRx Pharmaceuticals’ therapy, Zyesami® (aviptadil), in the treatment of critical …
News
credit_-_crevis_shutterstock_340710245_720

Pfizer and Entia’s breast cancer home test in final stages

November 5, 2021 Medical Communications

Pfizer UK and Entia’s home blood monitoring device for breast cancer patients is in late-stage development, with regulatory approvals expected …
News

Republicans governors retaliate against Biden vaccine mandate

November 5, 2021 Medical Communications

Republican governors are expected to sue in response to the Biden administration’s requirement that US employers ensure workers are tested …
News

Scientists identify new drug combination for children with brain cancer

November 5, 2021 Medical Communications

A new study has shown that combining two existing cancer drugs for leukaemia and melanoma could offer a promising future …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026